Patent · US Expired

Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF

US6417158B1 · kind B1 · utility

7Cited by
31References
44Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 1995
Grant dateJul 9, 2002
Priority date
Expiry dateJun 7, 2015

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S930/144
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

DNA sequences coding for a TNF-binding protein and for the TNF receptor of which this protein constitutes the soluble domain. The DNA sequences can be used for preparing recombinant DNA molecules in order to produce TNF-binding protein and TNF receptor. Recombinant TNF-binding protein is used in pharmaceutical preparations for treating indications in which TNF has a harmful effect. With the aid of the TNF receptor or fragments thereof or with the aid of suitable host organisms transformed with recombinant DNA molecules containing the DNA which codes for the TNF receptor or fragments or modifications thereof, it is possible to investigate substances for their interaction with the TNF receptor and/or for their effect on the biological activity of TNF.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.